HomeCannabis

Cannabis

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

September 13, 2022

22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board

22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board

September 13, 2022

High Fusion’s Psychedelics Subsidiary Neural Therapeutics Announces Significant Business and Corporate Milestones

High Fusion’s Psychedelics Subsidiary Neural Therapeutics Announces Significant Business and Corporate Milestones

September 13, 2022

YourWay Cannabis Brands Provides Corporate Update

YourWay Cannabis Brands Provides Corporate Update

September 13, 2022

MariMed To Launch Award-Winning Brands in Michigan Adult-Use Cannabis Market

MariMed To Launch Award-Winning Brands in Michigan Adult-Use Cannabis Market

September 13, 2022

Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

September 12, 2022

ReneSola Power Launches Inaugural Environmental, Social and Governance (ESG) Report

ReneSola Power Launches Inaugural Environmental, Social and Governance (ESG) Report

September 12, 2022

MariMed’s Brands and Products to Enter Missouri Market

MariMed’s Brands and Products to Enter Missouri Market

September 12, 2022

NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

September 12, 2022

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q at The Society for the Study of Behavioural Phenotypes (SSBP) 24th International Research Symposium

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q at The Society for the Study of Behavioural Phenotypes (SSBP) 24th International Research Symposium

September 9, 2022

« 1 … 131 132 133 134 135 … 144 »